BriaCell Therapeutics Corp. (BCTX) NASDAQ
3.27
-0.04(-1.21%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
3.27
-0.04(-1.21%)
Currency In USD
| Market Cap | 14.05M |
| Enterprise Value | -374,136 |
| P/E Ratio | -0.31 |
| PEG Ratio | 0.01 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 0.3 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | 0.77 |
| Fiscal Year | July 31, 2025 |
| Most Recent Quarter | January 31, 2026 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -0.88 |
| Return On Equity | -1.66 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | -147,888 |
| EBITDA | -37.58M |
| Net Income | -36.49M |
| Diluted EPS | -62.6 |
| Total Cash | 29.9M |
| Total Cash/Share | 10.58 |
| Total Debt | 0 |
| Total Debt/Equity | 0 |
| Current Ratio | 10.19 |
| Book Value Per Share | 10.79 |
| 52-Week Change | -90.58 |
| 52-Week High | 36 |
| 52-Week Low | 2.98 |
| Moving Average 50 Days | 4.01 |
| Moving Average 200 Days | 7.02 |
| Average Volume | 225,915 |
| Shares Outstanding | 1.88M |
| % Held by Institutions | 13.8 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:10 |
| Last Split Date | August 25, 2025 |